Showing results (1731-1740 of 2,560) with videos related to

Sort By:
Pageof 256
Minerva Cardiology and Angiology|October 29, 2025
Evolution and long-term impact of concomitant valvulopathies in patients undergoing transcatheter aortic valve implantationSilvia Malara, Francesco Burzotta, Francesca Graziani, et al.
Plos One|October 3, 2013
PARP-1 modulates amyloid beta peptide-induced neuronal damageSara Martire, Andrea Fuso, Dante Rotili, et al.
Sleep Medicine|February 13, 2014
Excessive fragmentary myoclonus in Machado-Joseph diseaseDiogo Fernandes dos Santos, José Luiz Pedroso, Pedro Braga-Neto, et al.
BMC Oral Health|February 4, 2023
MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case seriesRodolfo Mauceri, Martina Coppini, Massimo Attanasio, et al.
Andrology|February 11, 2025
Comprehensive diagnostic and therapeutic approach to male factor infertility aimed at natural fertility: A multicentric retrospective cohort studyGiuseppe Grande, Andrea Garolla, Andrea Graziani, et al.
European Journal of Medicinal Chemistry|January 6, 2019
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screeningSuresh Velnati, Elisa Ruffo, Alberto Massarotti, et al.
Plos One|May 31, 2017
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugateSujiet Puthenveetil, Haiyin He, Frank Loganzo, et al.
Journal of Clinical Periodontology|December 1, 2020
The staging and grading system in defining periodontitis cases: consistency and accuracy amongst periodontal experts, general dentists and undergraduate studentsLorenzo Marini, Maurizio S Tonetti, Luigi Nibali, et al.
Journal of Psychosocial Nursing and Mental Health Services|August 22, 2018
First-Episode Psychosis from the Perspective of Family MembersAmanda Heloisa Santana da Silva, Kelly Graziani Giacchero Vedana, Larissa de Souza Tressoldi, et al.
Biochemical Pharmacology|March 22, 2015
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenibGrazia Graziani, Simona Artuso, Anastasia De Luca, et al.
Pageof 256